In JDM patients, pro-platelet basic protein (PPBP; or NAP2), IL1RL1, TNFSF13B, CXCL9, GDF15, and WFDC2 correlated with JDM skin disease activity, but not with muscle disease activity. This evidence concerns the gene CXCL9 and juvenile dermatomyositis.